The MMPU is co-directed by Matthias Hentze (left), Jan Korbel (middle) and Andreas Kulozik (right).

The MMPU is a joint venture between the Medical Faculty of the University of Heidelberg and the European Molecular Biology Laboratory (EMBL). The MMPU drives innovation and its translation into medicine, leveraging its internationality and interdisciplinarity at the interface of molecular research and health care.

Research in the MMPU focuses on common diseases, as well as on rare diseases with a particular medical need. One MMPU hallmark is that it is staffed by both institutions and each research group is headed by two or more cooperating principal investigators. The MMPU is co-directed by Prof. Andreas Kulozik from the Angelika-Lautenschläger Hospital for Children and Adolescents at the Heidelberg University, by Prof. Matthias Hentze and by Dr. Jan Korbel from EMBL.  

Currently, the MMPU consists of 8 international teams of molecular research-oriented MDs, PhDs, PhD students and technicians. The research philosophy aims at the molecular understanding of the basis of common human diseases, its applications in diagnosis and therapy, and feedback from 'bedside medicine' into the research laboratory. Research themes place emphasis on the diseases of childhood, particularly blood disorders and childhood cancers and on diseases of adolescence, particularly hemochromatosis, chronic pain and cancers.

The MMPU has an international orientation, with regular team meetings, two annual public research days, and an attractive seminar programme.

The cooperation with the EMBL includes participation in all of EMBL's research activities, access to its scientific core facilities and affiliation with the EMBL International PhD Programme (EIPP) and the EMBL Interdisciplinary Postdocs (EIPOD) programme. Likewise, the Medical Faculty provides full access to its facilities, provides the laboratory space for the MMPU and funds scientists through its post-doc fellowship programme. Predoctoral as well as postdoctoral fellows strongly benefit from the sharing of medical and basic science expertise. The Heidelberg Research Centre for Molecular Medicine (HRCMM) is part of the Excellence Initiative II of Heidelberg University and funds fellowships for medical students and scientifically orientated physicians to do top-level international research.

Since summer 2011, the MMPU labs are united in common space in the Otto-Meyerhof-Zentrum (OMZ) on the Medical Campus of Heidelberg University (Google Map directions), within walking distance from the German Cancer Research Centre (DKFZ) and the Centre for Molecular Biology of Heidelberg University (ZMBH), and a short drive from EMBL.

All MMPU websites can also be viewed via the University Hospital Heidelberg webpages. (Currently under construction, August 2019)


EMBL Otto Meyerhof-Zentrum in Heidelberg (OMZ)